| http://www.w3.org/ns/prov#value | - For example, by increasing hemostatic or thrombolytic activity, KGF-2 polynucleotides or polypeptides could be used to treat blood coagulation disorders (e.g., afibrinogenemia, factor deficiencies), blood platelet disorders (e.g. thrombocytopenia), or wounds resulting from trauma, surgery, or other causes.
|
